POSTMENOPAUSAL WOMEN
Clinical trials for POSTMENOPAUSAL WOMEN explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL WOMEN trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL WOMEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Acupuncture needles take on belly fat in menopause study
Disease control Not yet recruitingThis study tests whether adding electroacupuncture to a standard diet and medication plan can reduce central obesity and fatty liver in postmenopausal women. Sixty women aged 50-60 with obesity will receive the same diet and orlistat for 12 weeks, but half will also get electroac…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can pelvic exercises boost estrogen therapy for bladder control?
Symptom relief Not yet recruitingThis study looks at whether adding pelvic floor muscle training to vaginal estrogen therapy helps postmenopausal women with stress urinary incontinence more than estrogen alone. About 115 women will be randomly assigned to either the combined treatment or estrogen-only group. The…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Knee replacement may not fully restore balance in older women
Knowledge-focused Not yet recruitingThis study will compare balance, walking ability, fall risk, and quality of life between postmenopausal women who have had a total knee replacement and healthy women of the same age. Researchers will test 30 women aged 60 and older using simple physical tests and a questionnaire.…
Matched conditions: POSTMENOPAUSAL WOMEN
Sponsor: Karabuk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New breast cancer drug candidate BL0175 enters first human safety trial
Knowledge-focused Not yet recruitingThis Phase 1 study will test a single injection of BL0175, a new polymer-linked form of the breast cancer drug fulvestrant, in 27 healthy postmenopausal women. The goal is to see if BL0175 is safe and how long it stays in the body compared to standard fulvestrant. This is an earl…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: PHASE1 • Sponsor: Shanghai Best-Link Bioscience, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC